WASHINGTON—Demand for long-lasting factory goods fell sharply in June, a sign overseas turmoil is weighing on U.S. manufacturers.
The iPhone maker provided another sober reminder of how its days of hyper growth are long gone. Apple (AAPL, Tech30) posted its second-straight quarter of shrinking sales, led by another drop in smartphone shipments.
WASHINGTON—A measure of homes under contract for sale rose slightly in June, as ongoing job growth and low interest rates continued to support the U.S.
Teva Pharmaceutical Industries Ltd. TEVA 1.49 % on Wednesday won regulatory approval from the Federal Trade Commission for its acquisition of Allergan PLC's generics business, conditioned upon Teva's divestiture of 75 drugs to rivals.
Video may have killed the radio star, but it could offer a lifeline to Twitter Inc. Just don't expect a turnaround in the company's flagging fortunes anytime soon, analysts said.